INZY
T. Rowe Price Associates’s Inozyme Pharma INZY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,533
| Closed | -$18K | – | 3098 |
|
|
2025
Q1 | $18K | Hold |
19,533
| – | – | ﹤0.01% | 3007 |
|
|
2024
Q4 | $55K | Buy |
19,533
+2,930
| +18% | +$8.25K | ﹤0.01% | 2918 |
|
|
2024
Q3 | $87K | Buy |
16,603
+233
| +1% | +$1.22K | ﹤0.01% | 2845 |
|
|
2024
Q2 | $74K | Buy |
16,370
+2,148
| +15% | +$9.71K | ﹤0.01% | 2795 |
|
|
2024
Q1 | $109K | Buy |
14,222
+1,526
| +12% | +$11.7K | ﹤0.01% | 2765 |
|
|
2023
Q4 | $55K | Buy |
+12,696
| New | +$55K | ﹤0.01% | 2795 |
|